INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Open-market purchaseVerified data

Saba Capital Management, L.P. bought GRX

10% Owner · Gabelli Healthcare & WellnessRx Trust · Common Stock

Side
BUY
Value
$42K
Shares
4,439
Price
$9.41
Executed
Oct 6, 2026
Disclosed
Oct 8, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 6 executedOct 8, 2026 disclosed

GRX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
29/ 100 · ROUTINE
Methodology →
  • Transaction type+20 / 20

    Open-market purchase

  • Relative size+1 / 25

    $42K reported value · 0.2% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · GRX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    25
    Saba Capital Management, L.P.10% Owner
    GRXGabelli Healthcare & WellnessRx Trust
    Open-market purchase
    		BUY$1,018
    100 sh
    		Nov 3, 2026Nov 4, 2026
    traded Nov 3, 2026
    		+1dSEC FORM 4

    Evidence

    25
    Saba Capital Management, L.P.10% Owner
    GRXGabelli Healthcare & WellnessRx Trust
    Open-market purchase
    		BUY$5,045
    500 sh
    		Oct 29, 2026Oct 30, 2026
    traded Oct 29, 2026
    		+1dSEC FORM 4

    Evidence

    25
    Saba Capital Management, L.P.10% Owner
    GRXGabelli Healthcare & WellnessRx Trust
    Open-market purchase
    		BUY$2,997
    300 sh
    		Oct 27, 2026Oct 28, 2026
    traded Oct 27, 2026
    		+1dSEC FORM 4

    Evidence

    25
    Saba Capital Management, L.P.10% Owner
    GRXGabelli Healthcare & WellnessRx Trust
    Open-market purchase
    		BUY$13K
    1,284 sh
    		Oct 26, 2026Oct 27, 2026
    traded Oct 26, 2026
    		+1dSEC FORM 4

    Evidence

    25
    Saba Capital Management, L.P.10% Owner
    GRXGabelli Healthcare & WellnessRx Trust
    Open-market purchase
    		BUY$28K
    2,955 sh
    		Oct 7, 2026Oct 9, 2026
    traded Oct 7, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001510281-26-000331
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 6, 2026
    Published
    Oct 8, 2026
    Ingested by INSIDER
    Nov 5, 02:12 UTC
    Last re-read
    Nov 5, 02:12 UTC

    Extracted facts

    Filer
    Saba Capital Management, L.P.
    Role
    10% Owner
    Transaction
    Open-market purchaseAs filed: “P”
    Asset
    Gabelli Healthcare & WellnessRx Trust
    Ticker
    GRX
    Shares
    4,439
    Price per share
    $9.41
    Value
    $41,771
    Execution date (reported)
    Oct 6, 2026
    Owned after transaction
    2.17M shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 4,439
    • Price: $9.41

    = $41,771

    What this establishes

    Saba Capital Management, L.P. filed this Form 4 reporting a open-market purchase of GRX on Oct 6, 2026. It became public on Oct 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    10% Owner
    Saba Capital Management, L.P.cik:0001510281
    Issuer
    Gabelli Healthcare & WellnessRx Trustcik:0001391437

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.